In regions with a large animal production sector, the viruses that cause these diseases - of the genus Morbillivirus - have significant repercussions on the local economy and food security: in Senegal, the economic impact of a peste des petits ruminants focus was estimated in 1996 at 80 000 euros over three months.
Rinderpest affects domestic cattle, buffaloes and yaks, but also sheep, goats and some pig races, along with a whole range of wild species. Despite a sustained blanket preventive vaccination campaign that has almost wiped out the disease on a global level, there are still some persistent infection foci in the Somali ecosystem. And there is no cure. As regards peste des petits ruminants, which affects sheep and goats, it is found in Africa, on the Arabian Peninsula, in the Middle East and in India. The available preventive vaccines are effective, but still have some drawbacks, such as their low heat resistance. There is no therapeutic treatment against this disease either.
Since early 2005, CIRAD has been developing a new control method against these diseases, based on a novel technique derived from molecular genetics. This new approach centres on a natural biological mechanism: "RNA interference", which usually allows multicellular organisms to control the level of expression of some of their genes. The process involves short RNA fragments capable of preventing the reading and translation into proteins of the genetic code carried by DNA: the fragments are known as interfering RNA. They prevent the RNA playing its fundamental role as a messenger of the information contained in the genes with a view to protein production. In effect, so-called interfering RNA links specifically to the target messenger RNA, resulting in the latter's deterioration and consequently inhibiting expression of the corresponding protein.
Interfering RNA inhibits more than 80% of virus replication
CIRAD researchers have recently identified three synthetic interfering RNAs capable of inhibiting more than 80% of peste des petits ruminants and rinderpest virus replication in vitro. They are targeted at the messenger RNA of the nucleoprotein gene of the viruses that cause the diseases, blocking the virus multiplication process. An application was made for a patent on the results concerning these new biological antivirals in December 2005.
The second phase of the research has now begun: in vivo tests of the new generation of antivirals on infected animals. To this end, the plan is to transfer the interfering RNA to infected animals through a viral vector generally used as a vaccine. If this is indeed seen to inhibit virus replication in the diseased animals, this would open the way for the development of therapeutic vaccines against rinderpest and peste des petits ruminants. The work is due to last for five years, and should make it possible to provide farmers with a safe, effective vaccine.
The results look very promising, and open up vast prospects in terms of animal health. They could be of interest for other viruses such as bird flu or African swine fever. For this last disease, using RNA interference as a control method would be a major step forward, as there is not currently any preventive vaccine.
Helen Burford | alfa
How much drought can a forest take?
20.01.2017 | University of California - Davis
Plasma-zapping process could yield trans fat-free soybean oil product
02.12.2016 | Purdue University
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences